Centessa Pharmaceuticals to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Company Overview - Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company focused on discovering and developing transformational medicines for patients [3] - The company is pioneering a new class of potential therapies within its orexin receptor 2 (OX2R) agonist program, targeting excessive daytime sleepiness (EDS), impaired attention, cognitive deficits, fatigue, and other symptoms related to neurological, neurodegenerative, and neuropsychiatric disorders [3] Upcoming Events - Members of Centessa Pharmaceuticals' management team will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference in New York, scheduled for September 9th at 4:50 PM ET [1] - A live audio webcast of the event will be available on the investor relations section of the Centessa Pharmaceuticals website, along with an archived recording [2]